Registrations are now open to attend our 2019 Symposium in Lyon, France from 16th to 18th October. Call for poster is also open until 15th July 2019.
This year attached to its 2019 symposium, the GMP offers to its members two satellite sessions in the morning of Wednesday 16th October.
Satellite 1 : Update and progress on microsampling application in pharmacokinetics
Satellite 2 : Pharmacokinetic modelling for antibodies with Targeted Mediated Drug Disposition : Theory, case study and example of practical applications
See attached details – Conference provided in French. Register soon : number of attendees is limited !
The AFPT – Le Club Phase 1 in collaboration with PhinC Development and Roche is organizing the third edition of the PBPK symposium
The event on the theme of “Physiologically Based PharmacoKinetic modelling: a new Paradigm in Drug Development” will be held on 4 April 2019 at the Maison de la Chimie in Paris.
Public: Scientists and clinicians working in clinical pharmacology research, pharmaceutical industry, regulatory bodies, and academic students.
Dear colleagues, dear members, we have now entered 2019, and the new GMP board would like to present you its best wishes for accomplishment and success in your projects. The board has started its mission to provide you various and attractive events along this new year.
Group of Metabolism and Pharmacokinetics (GMP) will be organising its Annual Symposium on Drug metabolism and Pharmacokinetics from 16 to 18 October 2019 at Lyon (Château de Montchat, Place du château, 69003 Lyon).
GMP invites its members, Research scientists from Industry and CRO and Academia, and students to book these dates.
Preliminary agenda and call for abstract will be communicated early 2019
Dear Colleagues and GMP members,
For 2 years, the GMP's board offers the opportunity to its members to participate to the Scientific Committee (SC). This committee includes the GMP's board members and GMP members who have responded positively to this offer.
The past 2 years demonstrated that the diversity of expertise and the involvement of GMP members in the SC allow us to propose a high-quality scientific program.
we are grateful that Dr Daniel Kramer, global scientific advisor immunogenicity at sanofi R&D and chairman of the European Immunogenicity Platform (EIP) is willing to offer this (30’) presentation and (15’) dialogue with you about “Immunogenicity of Biologics and its clinical consequences” Wednesday 01 October 01:30-02:30 pm (CEST).
All our members will receive an invitation with Webmeeting link. If you are interested, please join our members http://app.gmp.asso.fr/ or contact GMP board on our website for further information.
The GMP board.